Compassionate Care of Gwynedd: The Debility-Diagnosis Settlement

Whistleblower Justice Network

In the Compassionate Care Gwynedd settlement, Compassionate Care of Gwynedd Inc. agreed to pay $2 million to resolve hospice fraud allegations that it admitted patients using medically unjustified debility diagnoses. For someone inside admissions, nursing or billing, the question goes straight to the work: did the diagnosis used to enroll the patient match the person the clinical team assessed?

The Department of Justice announced the settlement on July 6, 2017. The defendant operated in Bensalem, Pennsylvania, as a subsidiary of Compassionate Care Hospice Group Inc.

What the Gwynedd Settlement Alleged

The government alleged that Gwynedd admitted patients who did not need hospice care from January 1, 2005 through November 15, 2011, using debility diagnoses that were not medically justified.

When the diagnosis lacks medical support, the problem reaches beyond a word in a chart: it reaches the decision to put that patient into a benefit for people approaching death.

During the later part of that period, the Centers for Medicare & Medicaid Services required physicians to explain the prognosis in an individualized narrative. The agency’s hospice coverage manual describes the requirement: the explanation must reflect the patient’s own clinical circumstances. A form filled in the same way for every patient was not enough.

What Makes Someone Ineligible for Hospice?

A patient whose condition does not support the required terminal prognosis is ineligible for Medicare hospice care. Medicare’s hospice coverage manual requires a medical prognosis of six months or less if the illness runs its normal course.

That is why hospice eligibility turns on the patient’s individual condition. The clinical information has to support the prognosis. For the Gwynedd allegations, the question was what justified the debility diagnosis when the patient entered hospice.

The stakes extend to the patient as well as Medicare. Choosing hospice shifts coverage for treatment of the terminal illness into hospice. Medicare payment outside hospice for that treatment is waived, apart from certain independent attending-physician services. Coverage for unrelated health care remains. An unsupported enrollment changes the patient’s access to coverage while creating a stream of payments to the provider.

The Later Change to Debility Coding

Medicare later stopped accepting debility or adult failure to thrive as the principal hospice diagnosis. The Centers for Medicare & Medicaid Services reported in its fiscal year 2016 hospice rule that it returned those claims effective October 1, 2014. The Gwynedd settlement concerned whether the earlier admission diagnoses were medically justified.

Why an Admission Diagnosis Matters to Payment

Medicare’s routine hospice payment follows the enrolled day, including days without a staff visit. When a hospice bills for an ineligible patient throughout a stay, taxpayers pay repeatedly for care that patient did not qualify to receive. The diagnosis opens the door, and the daily payment makes the admission financially consequential. The patient gives up coverage for treatment of the terminal illness outside hospice while the healthcare provider gains paid days.

The work is uneven across a stay. Milliman’s 2019 report Hospice Medicare Margins, commissioned by the National Partnership for Hospice Innovation, analyzed Medicare claims and hospice cost reports. It found that nursing and social worker visits were concentrated near admission and death, a pattern seen in both nonprofit and for-profit hospices. The quieter middle of a stay can carry fewer visits while enrolled days continue to generate payment.

That payment structure explains why the admission decision belongs in a hospice billing investigation. We connect the medical explanation for enrollment with the claims that followed it. The clinical and billing sides of the business each hold part of that connection.

A Debility Diagnosis in Another Hospice Case

SouthernCare also faced allegations that it billed Medicare for patients who were ineligible for hospice. The Justice Department’s January 2009 settlement announcement describes cases brought by former employees over those admissions.

A separate, later SouthernCare whistleblower complaint makes the diagnosis issue concrete. It alleged that a terminally ill man’s wife was enrolled alongside him with a diagnosis of debility, unspecified. The complaint described a woman enrolled for end-of-life care, then discharged because she had not declined:

After approximately two (2) months on hospice, Patient 4 was discharged for “failure to decline”.

Whistleblower’s allegation, United States ex rel. Patricia Beegle v. SouthernCare, Inc., complaint, paragraph 46

The alleged admission rested on debility. The later discharge rested on the absence of decline. Those are decisions at opposite ends of the same stay. Someone who knows what staff observed between them can explain much more than the diagnosis field alone.

The Parent Company’s Separate Referral Settlement

Compassionate Care Hospice Group and Compassionate Care Hospice of Atlanta agreed to a separate $2.4 million settlement over alleged payments to physicians for referrals and eligibility certifications. The Justice Department announced that settlement the same day as Gwynedd’s.

The government alleged that a medical director received payments in exchange for referrals and that associate medical directors held sham contracts. The alleged payments bought access to patients and the physician approvals needed to admit them. Here, the question reached beyond what the diagnosis said to the financial relationship behind the referral and certification.

These hospice referral kickback allegations involved the parent and Atlanta operation. The Gwynedd allegations concerned the medical justification for debility admissions. Both cases put the route into hospice under scrutiny: who brought the patient in, who approved the admission and what supported that approval. For an insider, the clinical chart and the medical-director contract can illuminate different parts of that decision.

Whistleblowers Behind the Gwynedd Case

Two whistleblowers brought the Gwynedd case, and DOJ announced a share of the recovery for them.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

You Saw the Patient Behind the Diagnosis

If you saw debility diagnoses used to admit patients whose clinical records told a different story, speak to our whistleblower experts about how those patients were admitted. We connect the clinical decisions to the Medicare claims and bring in hospice fraud whistleblower lawyers who know eligibility cases. We stay alongside you throughout the case to build your strongest hospice whistleblower case.

WHISTLEBLOWER JUSTICE NETWORK CAN HELP YOU
Make a difference.
Whistleblower Justice NetworkReport Fraud
100% CONFIDENTIALFREE CONSULTATION24 / 7 / 365